Description

Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. The global generic injectables market is poised to grow by US$ 49.3 billion from 2022 to 2028, registering a CAGR of 8.7% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for generic injectables. The global generic injectables market is segmented on the basis of product, route of administration, application, and region. By product, the global generic injectables market has been segmented into large molecule, small molecule. Based upon route of administration, the global generic injectables market is categorized into intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, others. On the basis of application, the global generic injectables market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, others. In terms of geography, the global generic injectables market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global generic injectables market is highly competitive. Top players covered in Global Generic Injectables Market Study are AstraZeneca plc, Baxter International Inc., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Lupin Limited, Merck & Co. Inc., Mylan N.V., Pfizer Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the generic injectables market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: large molecule, small molecule
Route of administration: intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, others
Application: oncology, infectious diseases, cardiology, diabetes, immunology, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global generic injectables market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Generic injectables market overview
Part 3. Market breakdown by product
– Large molecule
– Small molecule
Part 4. Market breakdown by route of administration
– Intravenous (IV) generic injectables
– Intramuscular (IM) generic injectables
– Subcutaneous (SC) generic injectables
– Others
Part 5. Market breakdown by application
– Oncology
– Infectious diseases
– Cardiology
– Diabetes
– Immunology
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– AstraZeneca plc
– Baxter International, Inc.
– Dr. Reddy’s Laboratories Ltd.
– Fresenius SE & Co. KGaA
– Hikma Pharmaceuticals plc
– Lupin Limited
– Merck & Co., Inc.
– Mylan N.V.
– Pfizer, Inc
About StrategyHelix
Disclaimer